Cap insulin copayments for Medicare beneficiaries at $35 per month.

For the estimated 5,100 Medicare beneficiaries receiving insulin in the district, the new law will cap monthly copayments for insulin products at $35 per month.

Casten notes the IRA's insulin copay cap for Medicare beneficiaries.

Rep. Sean Casten Releases Reports Showing the Inflation Reduction Act Will Lower Health Care Costs for Local Families | U.S. Congressman Sean Casten
primary · other · model gpt-5.4-mini

legacy_unverified · Source version not recorded · locator unknown

Medicare.gov states that Medicare-covered insulin has no more than a $35 cost for a one-month supply of each Part B- and Part D-covered insulin product, and that the deductible does not apply to insulin.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Current Medicare guidance shows the promised $35 monthly insulin cost cap for Medicare beneficiaries is in effect for both Part B and Part D covered insulin products.

delivered same_term

Medicare.gov: Insulin
secondary · model gpt-5.5 · confidence 98%

legacy_unverified · Source version not recorded · locator unknown

The House Clerk records Roll Call 420 on H.R. 5376, the Inflation Reduction Act, as passed on August 12, 2022; Rep. Sean Casten of Illinois is listed as voting Yea.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Casten voted for final House passage of the Inflation Reduction Act, the enacted law that created the Medicare insulin copayment cap.

delivered same_term A for effort

Office of the Clerk, U.S. House: Roll Call 420, H.R. 5376
secondary · model gpt-5.5 · confidence 95%